Use access key #2 to skip to page content.
$27.29 0.26 (0.96%)
8/28/2008 4:00 PM

Vertex Pharmaceuticals, Inc. (VRTX)

CAPS Rating:
****

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.

View Ticker Page (VRTX)

Results 41 - 50 of 114 :   12345Next »

Recs

0

Avatar pjani06 (73.81) Submitted: 4/16/08 2:21 AM : Outperform Start Price: $25.87 VRTX Score: 8.25

In a climate where innovation has dried up, this company seems to deliver. Peers have been hit hard in this market climate however this one stood out and I believe for reason. Look for VRTX to lead long term.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar pshea12 (98.04) Submitted: 4/24/08 2:42 PM : Underperform Start Price: $25.16 VRTX Score: -15.16

Way too expensive. Its a good company, no doubt, but you will be paying heftily to be part of it. All of the upsides this stock offers cost too much and the potential for loss seems more probible than doing any better than it already is doing. Loo...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar riloburnham (43.65) Submitted: 4/24/08 9:38 PM : Outperform Start Price: $24.85 VRTX Score: 16.46

Vertex Pharmaceuticals Inc. released more positive data on its hepatitis C drug candidate telaprevir. The has declined recentley making it a good buy.
The stock fell $1.05, or 4.1 percent, to $24.90, adding to Wednesday's 3.8 percent decline. Shares...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar YoungInvestor99 (22.44) Submitted: 5/06/08 8:08 PM : Outperform Start Price: $26.33 VRTX Score: 11.94

Rule breaker sept. 2007

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar marcd147 (97.73) Submitted: 5/17/08 10:09 PM : Outperform Start Price: $27.51 VRTX Score: 8.04

very interresting pipeline of drugs; currently leading they way in their niche

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar F4Phanatic (99.15) Submitted: 7/03/08 9:30 PM : Outperform Start Price: $34.04 VRTX Score: -22.49

Vertex Pharmaceuticals represents an attractive long-term opportunity based on the potential blockbluster sales of Telaprevir. Other potential pipeline candidates also look interesting, but Vertex is burning cash at a significant rate, thus frustrati...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar Aquadoloop (44.44) Submitted: 7/17/08 4:57 PM : Outperform Start Price: $32.40 VRTX Score: -18.89

Up up and away. Great stock with great product.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar highlandspring (< 20) Submitted: 7/29/08 11:20 PM : Outperform Start Price: $32.97 VRTX Score: -19.71

Promising new hepatitis C drug

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar jec00702 (53.23) Submitted: 7/31/08 12:08 PM : Outperform Start Price: $34.66 VRTX Score: -23.25

Don't I repeat Don't invest in biotechnology unless you have some kind of expertise in this field. There is a ton of mind numbing data which is generated from testing. You can't value these companies in the same manner you would a financial stock. ...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar Budsworth (30.77) Submitted: 4/07/08 1:55 PM : Outperform Start Price: $26.28 VRTX Score: 9.40

This is the biggest news for millions of people carrying or suffering from Hepatitis C in years! The current treatments such as Roche's Pagasys, and other versions of the interferon are harsh treatments with a 14-16% rate of curing the disease. Verte...

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners